NCT03190915 2026-03-19Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic LeukemiaNational Cancer Institute (NCI)Phase 2 Active not recruiting10 enrolled 11 charts
NCT03975829 2026-02-13Pediatric Long-Term Follow-up and Rollover StudyNovartisPhase 4 Active not recruiting163 enrolled